This study reports the results of an open-label clinical trial testing the safety and efficacy of recombinant human interferon γ (IFNγ)-1b in a group of 12 young FRDA patients treated for 6 months.
Read the entire article HERE
SHARE
This study reports the results of an open-label clinical trial testing the safety and efficacy of recombinant human interferon γ (IFNγ)-1b in a group of 12 young FRDA patients treated for 6 months.
Read the entire article HERE
